Methods and drug delivery devices using cannabis
A method of purifying at least one of THC and CBD from a cannabis -containing composition includes heating the cannabis -containing composition to a temperature sufficient to volatilize at least one of THC and CBD into a vapor and condensing the vapor on a substrate. A drug delivery cartridge can include a substrate coated with at least one of THC and CBD and configured to allow for passage of air through the cartridge to volatilize at least one of THC and CBD for inhalation by a user to induce a medicinal or therapeutic effect to the user. A drug delivery system can be used with the drug delivery cartridge and can include a heating element to volatilize at least one of THC and CBD from the coated substrate into a vapor for inhalation.
1. A drug delivery product, comprising:
a cylindrical structure extending in a longitudinal direction and formed from a substrate of an electrically conductive material, the cylindrical structure comprising:
first and second electrodes extending laterally on the substrate at respective first and second longitudinal locations, the first and second electrodes each having an electrical resistance sufficient to conduct current laterally along the substrate;
a first substrate portion extending longitudinally between the first and second electrodes, the first substrate portion having an electrical resistance high enough to conduct current longitudinally between the first and second electrodes and resistively heat the first substrate portion in response to the current conducted therethrough;
a plurality of electrically insulating spacers positioned to space apart adjacent layers of the substrate; and
a first dose of a drug disposed on the first substrate portion and configured to volatilize into a gas in response to the resistive heating of the first substrate portion,
wherein the substrate is rolled to form the cylindrical structure having a spiral cross-section, when viewed from a longitudinal end of the rolled substrate.
2. The drug delivery product of claim 1 , wherein the first and second electrodes are attached to the substrate prior to rolling the substrate to form the cylindrical structure.
3. The drug delivery product of claim 1 , further comprising:
a housing configured to receive the cylindrical structure within a cavity in the housing, the cavity sized and shaped to correspond to the cylindrical structure,
the housing having first and second housing electrodes around a circumference of the cavity and facing inward toward the cavity,
the first and second housing electrodes being positioned longitudinally to respectively contact the first and second electrodes of the cylindrical structure when the cylindrical structure is inserted into the housing,
the first and second housing electrodes configured to deliver current between the first and second electrodes of the cylindrical structure.
4. The drug delivery product of claim 1 ,
wherein the cylindrical structure further includes a third electrode extending laterally across the cylindrical structure at a third longitudinal location, so that the second electrode is positioned longitudinally between the first and third electrodes;
wherein the third electrode has an electrical resistance small enough to conduct current laterally along the cylindrical structure,
wherein the cylindrical structure further includes a second substrate portion extending longitudinally between the second and third electrodes;
wherein the second substrate portion has an electrical resistance sufficient to conduct current longitudinally between the second and third electrodes and resistively heat the second substrate portion in response to the current conducted therethrough; and
wherein a second dose of the drug is disposed on the second substrate portion and configured to volatilize into a gas in response to the resistive heating of the second substrate portion.
5. The drug delivery product of claim 4 , further comprising:
a housing configured to receive the cylindrical structure within a cavity in the housing, the cavity sized and shaped to correspond to the cylindrical structure,
the housing having first, second, and third housing electrodes around a circumference of the cavity and facing inward toward the cavity,
the first, second, and third housing electrodes being positioned longitudinally to respectively contact the first, second, and third electrodes of the cylindrical structure when the cylindrical structure is inserted into the housing,
the first and second housing electrodes configured to deliver current between the first and second electrodes of the cylindrical structure,
the second and third housing electrodes configured to deliver current between the second and third electrodes of the cylindrical structure.
6. The drug delivery product of claim 5 , further comprising:
a controller positioned in the housing and configured to deliver current between the first and second housing electrodes to provide the first dose of the drug to a patient, and further configured to deliver current between the second and third housing electrodes to provide the second dose of the drug to the patient.
7. The drug delivery product of claim 6 , wherein the controller delivers current between the first and second housing electrodes at a first time to provide the first dose of the drug to a user and delivers current between the second and third housing electrodes at a second time, different from the first time, to provide the second dose of the drug to the user.
8. The drug delivery product of claim 5 , wherein the housing further comprises a mister configured to add a mist to the volatized first dose of the drug.
9. The drug delivery product of claim 8 , wherein the housing further comprises a misting reservoir hydraulically connected to the mister.
10. The drug delivery product of claim 1 , wherein the first and second electrodes are formed integrally with the substrate and are thicker than the first substrate portion.
11. A drug delivery product, comprising:
a cylindrical structure extending in a longitudinal direction and formed from a substrate of an electrically conductive material, the cylindrical structure comprising:
first and second electrodes extending laterally on the substrate at respective first and second longitudinal locations, the first and second electrodes each having an electrical resistance sufficient to conduct current laterally along the substrate;
a first substrate portion extending longitudinally between the first and second electrodes, the first substrate portion having an electrical resistance high enough to conduct current longitudinally between the first and second electrodes and resistively heat the first substrate portion in response to the current conducted therethrough;
a first dose of a drug disposed on the first substrate portion and configured to volatilize into a gas in response to the resistive heating of the first substrate portion;
a third electrode extending laterally across the cylindrical structure at a third longitudinal location, so that the second electrode is positioned longitudinally between the first and third electrodes, the third electrode having an electrical resistance small enough to conduct current laterally along the cylindrical structure;
a second substrate portion extending longitudinally between the second and third electrodes, the second substrate portion having an electrical resistance sufficient to conduct current longitudinally between the second and third electrodes and resistively heat the second substrate portion in response to the current conducted therethrough;
a second dose of the drug is disposed on the second substrate portion and configured to volatilize into a gas in response to the resistive heating of the second substrate portion; and
a housing configured to receive the cylindrical structure within a cavity in the housing, the cavity sized and shaped to correspond to the cylindrical structure,
the housing having first, second, and third housing electrodes around a circumference of the cavity and facing inward toward the cavity,
the first, second, and third housing electrodes being positioned longitudinally to respectively contact the first, second, and third electrodes of the cylindrical structure when the cylindrical structure is inserted into the housing,
the first and second housing electrodes configured to deliver current between the first and second electrodes of the cylindrical structure,
the second and third housing electrodes configured to deliver current between the second and third electrodes of the cylindrical structure.
12. The drug delivery product of claim 11 , further comprising:
a controller positioned in the housing and configured to deliver current between the first and second housing electrodes to provide the first dose of the drug to a patient, and further configured to deliver current between the second and third housing electrodes to provide the second dose of the drug to the patient.
13. The drug delivery product of claim 12 , wherein the controller delivers current between the first and second housing electrodes at a first time to provide the first dose of the drug to a user and delivers current between the second and third housing electrodes at a second time, different from the first time, to provide the second dose of the drug to the user.
14. The drug delivery product of claim 11 , wherein the first and second electrodes are formed integrally with the substrate and are thicker than the first substrate portion.
15. The drug delivery product of claim 11 , wherein the housing further comprises a mister configured to add a mist to the volatized first dose of the drug.
16. The drug delivery product of claim 15 , wherein the housing further comprises a misting reservoir hydraulically connected to the mister.